Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?
- 12 April 2014
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 107, 23-30
- https://doi.org/10.1016/j.antiviral.2014.03.012
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Dendritic Cell and Macrophage Heterogeneity In VivoImmunity, 2011
- Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regressionHepatology, 2011
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- IL28B and the Control of Hepatitis C Virus InfectionGastroenterology, 2010
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009
- Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CHepatology, 2009
- Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patientsHepatology, 2008
- Senescence of Activated Stellate Cells Limits Liver FibrosisCell, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infectionCancer, 2003